Mossallam, Ghada I and Kamel, Azza M and Storer, Barry and Martin, Paul J (2009) Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 15 (3). pp. 352-359. ISSN 1523-6536
Preview |
Text (Complete manuscript)
MartinPChimerismResubmission.pdf Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (272kB) | Preview |
Abstract
The utility of routine chimerism analysis as a prognostic indicator of subsequent outcomes after allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning regimens remains controversial. To address this controversy, routine chimerism test results at 2 to 6 months after HCT with myeloablative conditioning regimens were evaluated for association with subsequent risk of chronic graft-versus-host disease (GVHD), nonrelapse mortality (NRM), relapse, and overall mortality. Only 70 of 1304 patients (5%) had < 95% donor-derived cells in the marrow. Low donor chimerism in the marrow occurred more often in patients with low-risk diseases compared with those with higher-risk diseases and was significantly associated with a reduced risk of chronic GVHD. Among 673 patients evaluated, 164 (24%) had < 85% donor-derived T cells in the blood. Low donor T cell chimerism was more frequent in patients with low-risk diseases compared with those with higher-risk diseases, in those who received conditioning with busulfan compared with those who received conditioning with total body irradiation, and in those with lower-grade acute GVHD. Low donor T cell chimerism in the blood was significantly associated with a reduced risk of chronic GVHD but not with a reduced risk of relapse, NRM, or overall mortality. Routine testing of chimerism in the marrow and blood at 2 to 6 months after HCT with myeloablative conditioning regimens may be helpful in documenting engraftment in clinical trials, but provides only limited prognostic information in clinical practice.
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | This article is available to subscribers only via the URL above. |
| DOI: | 10.1016/j.bbmt.2008.12.496 |
| PubMed ID: | 19203726 |
| NIHMSID: | NIHMS96988 |
| PMCID: | PMC2662135 |
| Grant Numbers: | P01 HL 36444, P01 CA 18029, BI01-002-002 Contract No. 188 |
| Keywords or MeSH Headings: | Adolescent Adult Aged Bone Marrow Cells/immunology* Child Child, Preschool Cohort Studies Female Follow-Up Studies Graft vs Host Disease/immunology Hematopoietic Stem Cell Transplantation/methods* Humans Infant Infant, Newborn Male Middle Aged Survival Analysis T-Lymphocytes/immunology Transplantation Chimera/immunology* Transplantation Conditioning/methods Treatment Outcome Young Adult |
| Subjects: | Therapeutics > Transplantation > Stem Cell transplantation |
| Depositing User: | Library Staff |
| Date Deposited: | 09 Mar 2009 19:02 |
| Last Modified: | 14 Feb 2012 14:42 |
| URI: | http://authors.fhcrc.org/id/eprint/257 |
Repository Administrators Only
 |
View Item |
